Homo sapiens
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA169016 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:CIDR GWAS Benign Neutropenia in African Americans
| PRJNA169015 | ENA
Project description:Substance Dependence GWAS in European- and African Americans
| PRJNA289552 | ENA
Project description:CIDR-GWAS of Breast Cancer in the African Diaspora
| PRJNA75839 | ENA
Project description:CIDR-GWAS of Breast Cancer in the African Diaspora
| PRJNA75837 | ENA
Project description:Type 2 Diabetes in African Americans, GWAS and Exome Sequencing
| PRJNA328295 | ENA
Project description:<p>Benign ethnic neutropenia (BEN) is a clinical condition more commonly observed in African-Americans. It is characterized by a relative reduction in neutrophil count by about 1000 cells per microliter, leading to a decrease in total leukocyte count by similar decrement. Previous reports of this condition showed that there was neither higher frequency nor increased severity of infections in affected individuals. Bone marrow examinations showed normal white cell maturation; and ex vivo culture of marrow cells showed low normal or slightly reduced number of myeloid colonies. Under physiologic stress, the increases in neutrophil and leukocyte counts of BEN individuals are slightly lower, compared to normal African-Americans or Caucasians. These clinical observations suggest that BEN results from a lower 'set point' for cell number in the marrow. Additionally, case reports of familial BEN, the persistence of BEN over many decades in the US, UK, and Africa, and the recent report of Duffy antigen and chemokine receptor (DARC) being associated with neutropenia, all suggest a strong genetic association to neutropenia/leukopenia. Our initial look into microarray analyses in a pilot trial of subjects showed that there were no significant differences in mRNA signals between BEN and normal subjects. Therefore, we are now proposing a larger study, utilizing Illumina Omni Express chips, to look for genetic associations. We have partnered with the Reasons for Geographic and Racial Differences in Stroke study (REGARDS), where nearly half of the cohort are African-Americans. This will be one of the few GWAS being performed in only African-Americans, and will provide valuable genetic information to link with neutropenia and possibly other conditions/diseases.</p> <p>Genotyping was performed by the Johns Hopkins University Center for Inherited Disease Research (CIDR). Quality control of the genotypic and phenotypic data was performed through a collaboration between CIDR and the Genetics Coordinating Center, Department of Biostatistics at the University of Washington, which is funded by a federal contract supported by 14 NIH Institutes (HHSN268200782096C).</p>
| phs000507 | dbGaP
Project description:CIDR: Type 2 Diabetes in African Americans
| PRJNA75501 | ENA
Project description:Collaborative Study on the Genetics of Alcoholism (COGA): CIDR: African American family GWAS
| PRJNA292978 | ENA